Halozyme Therapeutics, Inc.HALONASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+53.3%
5Y CAGR+33.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+53.3%/yr
vs +52.7%/yr prior
5Y CAGR
+33.8%/yr
Recent acceleration
Acceleration
+0.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 165.22 | +891.4% |
| 2024 | 16.67 | -71.4% |
| 2023 | 58.18 | +26.9% |
| 2022 | 45.86 | +59.7% |
| 2021 | 28.71 | -25.4% |
| 2020 | 38.51 | +38.1% |
| 2019 | 27.89 | +230.7% |
| 2018 | 8.43 | -36.4% |
| 2017 | 13.26 | +134.3% |
| 2016 | -38.69 | - |